Walter E. Kaufmann

Active 1989–2025

126
Papers
23,982
Citations
85
h-index
123
i10-index

Citations

Citations per year for Walter E. Kaufmann1939: 2 citations1980: 1 citations1989: 1 citations1990: 2 citations1991: 3 citations1992: 1 citations1993: 2 citations1994: 11 citations1995: 31 citations1996: 45 citations1997: 71 citations1998: 94 citations1999: 89 citations2000: 127 citations2001: 107 citations2002: 194 citations2003: 174 citations2004: 212 citations2005: 239 citations2006: 271 citations2007: 229 citations2008: 214 citations2009: 244 citations2010: 258 citations2011: 272 citations2012: 258 citations2013: 244 citations2014: 255 citations2015: 260 citations2016: 237 citations2017: 257 citations2018: 226 citations2019: 704 citations2020: 718 citations2021: 684 citations2022: 520 citations2023: 335 citations2024: 560 citations2025: 161 citations2026: 10 citations1940–1979: no citations, so these years are not shown1981–1988: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,718 citing papers, 39.9% of this breakdownUnited Kingdom: 690 citing papers, 7.4% of this breakdownCanada: 466 citing papers, 5% of this breakdownGermany: 464 citing papers, 5% of this breakdownItaly: 382 citing papers, 4.1% of this breakdownChina: 366 citing papers, 3.9% of this breakdownAustralia: 324 citing papers, 3.5% of this breakdownFrance: 311 citing papers, 3.4% of this breakdownNetherlands: 262 citing papers, 2.8% of this breakdownJapan: 237 citing papers, 2.6% of this breakdownSpain: 196 citing papers, 2.1% of this breakdownSwitzerland: 171 citing papers, 1.8% of this breakdown
0%39.9%Other 18.5%

Fields

  • Biochemistry, Genetics and Molecular Biology32.5%
  • Medicine30.6%
  • Neuroscience27.9%
  • Psychology4.9%
  • Social Sciences0.9%
  • Computer Science0.7%
  • Other2.5%

Topics

  • Genetics and Neurodevelopmental Disorders9.3%
  • Autism Spectrum Disorder Research6.9%
  • Advanced Neuroimaging Techniques and Applications4.6%
  • Neuroscience and Neuropharmacology Research4.1%
  • Functional Brain Connectivity Studies4%
  • Advanced MRI Techniques and Applications1.7%
  • Other69.4%

Coauthors

All papers

Open in search
  1. Rett syndrome: Revised diagnostic criteria and nomenclature

    Authors: , , , , , , , , , , , , - Annals of Neurology 2010 cited by 1,388

  2. Family income, parental education and brain structure in children and adolescents

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Nature Neuroscience 2015 cited by 1,435

  3. The Pediatric Imaging, Neurocognition, and Genetics (PING) Data Repository

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - NeuroImage 2015 cited by 334

  4. Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with disease severity in Rett syndrome

    Authors: , , , , , , , , , , , , - Journal of Medical Genetics 2014 cited by 315

  5. Double-blind, randomized, placebo-controlled study of trofinetide in pediatric Rett syndrome

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Neurology 2019 cited by 168

  6. The array of clinical phenotypes of males with mutations in Methyl‐CpG binding protein 2

    Authors: , , , , , , , , , , , , , , , - American Journal of Medical Genetics Part B Neuropsychiatric Genetics 2018 cited by 107

  7. Autism Spectrum Disorder in Fragile X Syndrome: Cooccurring Conditions and Current Treatment

    Authors: , , , , , , , , , , , - PEDIATRICS 2017 cited by 274

  8. A precision medicine framework using artificial intelligence for the identification and confirmation of genomic biomarkers of response to an Alzheimer's disease therapy: Analysis of the blarcamesine (ANAVEX2‐73) Phase 2a clinical study

    Authors: , , , , , , , , - Alzheimer s & Dementia Translational Research & Clinical Interventions 2020 cited by 80

  9. Longitudinal course of epilepsy in Rett syndrome and related disorders

    Authors: , , , , , , , , , - Brain 2016 cited by 129

  10. Towards a better diagnosis and treatment of Rett syndrome: a model synaptic disorder

    Authors: , , , , - Brain 2018 cited by 110

  11. Arc, a growth factor and activity-regulated gene, encodes a novel cytoskeleton-associated protein that is enriched in neuronal dendrites

    Authors: , , , , , , , , , - Neuron 1995 cited by 1,228

  12. A Psychometric Evaluation of the Motor-Behavioral Assessment Scale for Use as an Outcome Measure in Rett Syndrome Clinical Trials

    Authors: , , , , , , , , , , , , , , , , , - American Journal on Intellectual and Developmental Disabilities 2020 cited by 52

  13. Arbaclofen in fragile X syndrome: results of phase 3 trials

    Authors: , , , , , , , , , , - Journal of Neurodevelopmental Disorders 2017 cited by 184

  14. Developmental delay in Rett syndrome: data from the natural history study

    Authors: , , , , , , , , , , , , - Journal of Neurodevelopmental Disorders 2014 cited by 165

  15. A Novel Way to Measure and Predict Development: A Heuristic Approach to Facilitate the Early Detection of Neurodevelopmental Disorders

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Current Neurology and Neuroscience Reports 2017 cited by 97

  16. Advances in the Treatment of Fragile X Syndrome

    Authors: , , , , , , , , , , , , - PEDIATRICS 2008 cited by 603

  17. Common DNA methylation alterations in multiple brain regions in autism

    Authors: , , , , , - Molecular Psychiatry 2013 cited by 342

  18. Safety, pharmacokinetics, and preliminary assessment of efficacy of mecasermin (recombinant human IGF-1) for the treatment of Rett syndrome

    Authors: , , , , , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2014 cited by 212

  19. The Changing Face of Survival in Rett Syndrome and MECP2-Related Disorders

    Authors: , , , , , , , , - Pediatric Neurology 2015 cited by 124

  20. Individual differences in frontolimbic circuitry and anxiety emerge with adolescent changes in endocannabinoid signaling across species

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , U Hawaii, Co-PI of PING, Core Co-PI, Anders M. Dale, UC San Diego, Core Co-PI, Peter C.M. van Zijl, KKI, Joshua Kuperman, UC San Diego, Sarah S. Murray, Cinnamon S. Bloss, Nicholas J. Schork, Mark I. Appelbaum, UC San Diego, Anthony Gamst, UC San Diego, Wesley K. Thompson, UC San Diego, Hauke Bartsch, UC San Diego, Terry L. Jernigan, Anders M. Dale, Natacha Akshoomoff, Linda Chang, Thomas Ernst, Brian Keating, David G. Amaral, Elizabeth R. Sowell, Walter E. Kaufmann, Peter C.M. van Zijl, Stewart H. Mostofsky, B. J. Casey, Erika J. Ruberry, Alisa Powers, Bruce Rosen, Tal Kenet, Jean A. Frazier, David N. Kennedy, Jeffrey R. Gruen - National Academy of Sciences, Proceedings of the National Academy of Sciences 2016 cited by 103

  21. Placebo‐controlled crossover assessment of mecasermin for the treatment of Rett syndrome

    Authors: , , , , , , , , , , , , , , , , , , - Annals of Clinical and Translational Neurology 2018 cited by 85

  22. Neuroanatomical Assessment of Biological Maturity

    Authors: , , , , , , , , , , , , , , , , , , , , , - Current Biology 2012 cited by 363

  23. The NIH Toolbox Cognition Battery: Results from a large normative developmental sample (PING).

    Authors: , , , , , , , , , , , , , , , , , , , , - Neuropsychology 2013 cited by 218

  24. Psychometric Study of the Aberrant Behavior Checklist in Fragile X Syndrome and Implications for Targeted Treatment

    Authors: , , , , , , , , , - Journal of Autism and Developmental Disorders 2011 cited by 189